|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01498 PURAPHARM
Nominal 
0.445 -0.005 (-1.111%) | 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Turnover | 172,295 | -17.017% | 207,627 | 195,081 | 230,760 | 302,757 |
| Cost of Sales | (77,172) | -18.220% | (94,365) | (83,156) | (80,655) | (106,353) |
| Gross Profit | 95,123 | -16.015% | 113,262 | 111,925 | 150,105 | 196,404 |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (744) | -- | 1,264 | (46) | 2,060 | (3,221) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (149) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (20,486) | 38.747% | (14,765) | (36,514) | (34,699) | 17,386 | |
| Taxation | (1,320) | -66.335% | (3,921) | (1,161) | (5,204) | (5,412) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (21,806) | 16.697% | (18,686) | (37,675) | (39,903) | 11,974 | |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Net Finance Costs / (Income) | 9,148 | -29.315% | 12,942 | 13,064 | 13,730 | 13,428 |
| Depreciation & Amortisation | 20,251 | -6.660% | 21,696 | 21,384 | 28,308 | 28,250 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | -5.520 | 16.702% | -4.730 | -9.540 | -10.120 | 3.040 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.257 | -- | 0.330 | 0.546 | 0.894 | 1.335 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -21,806 |
| %Change | 16.697% |
| EPS / (LPS) | HKD -0.055 |
| NBV Per Share ($) | HKD 0.257 |